Nadav Kidron, President and CEO, 10% Owner at ORAMED PHARMACEUTICALS INC. (ORMP), bought 600 shares at $6.55 ($4K) on 2015-05-12, disclosed to the SEC on 2015-05-12.
Open-market purchase of $4k ORMP by President and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.55 | 200 | $1K | 33.1% |
| 2 | $6.62 | 100 | $662 | 16.7% |
| 3 | $6.63 | 200 | $1K | 33.5% |
| 4 | $6.64 | 100 | $664 | 16.8% |
| Total | $6.60 avg | 600 | $4K | 100% |
| Filing → |
| ORMP | SELL | 2021-08-11 | $4.4M | — | Filing → |
| ORMP | SELL | 2018-07-12 | $365 | — | Filing → |
| ORMP | BUY | 2018-07-12 | $722 | — | Filing → |